Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Grupp

Showing results (61-70 of 238) with videos related to

Pageof 24
Sort By:
Science Translational Medicine|August 12, 2011
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemiaMichael Kalos, Bruce L Levine, David L Porter, et al.
Pediatric Blood & Cancer|December 4, 2019
Subcutaneous immunoglobulin replacement following CD19-specific chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia in pediatric patientsDanielle E Arnold, Shannon L Maude, Colleen A Callahan, et al.
Cancer Immunology Research|August 9, 2014
Nature of tumor control by permanently and transiently modified GD2 chimeric antigen receptor T cells in xenograft models of neuroblastomaNathan Singh, Xiaojun Liu, Jessica Hulitt, et al.
British Journal of Haematology|May 11, 2011
Statins are active in acute lymphoblastic leukaemia (ALL): a therapy that may treat ALL and prevent avascular necrosisCecilia Sheen, Tiffaney Vincent, David Barrett, et al.
Journal of Visualized Experiments : Jove|August 22, 2023
Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell ProcessorRene Machietto, Nicholas Giacobbe, Jessica Perazzelli, et al.
Cytotherapy|May 17, 2017
Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell functionNathan Singh, Ted J Hofmann, Zachary Gershenson, et al.
Cancer Medicine|December 27, 2024
CD4<sup>+</sup> T Cells Mediate Dendritic Cell Licensing to Promote Multi-Antigen Anti-Leukemic Immune ResponseLuis Gil-de-Gómez, Joseph J Mattei, Jessica H Lee, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: stem cell transplantationStephan A Grupp, Christopher C Dvorak, Michael L Nieder, et al.
Transplantation and Cellular Therapy|April 8, 2021
Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric PatientsDanielle E Arnold, Derek MacMath, Alix E Seif, et al.
European Journal of Immunology|March 16, 2017
IFN-γ directly inhibits murine B-cell precursor leukemia-initiating cell proliferation early in lifeMario Fidanza, Alix E Seif, Sumin Jo, et al.
Pageof 24

Showing results (61-70 of 238) with videos related to

Sort By:
Pageof 24
Science Translational Medicine|August 12, 2011
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemiaMichael Kalos, Bruce L Levine, David L Porter, et al.
Pediatric Blood & Cancer|December 4, 2019
Subcutaneous immunoglobulin replacement following CD19-specific chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia in pediatric patientsDanielle E Arnold, Shannon L Maude, Colleen A Callahan, et al.
Cancer Immunology Research|August 9, 2014
Nature of tumor control by permanently and transiently modified GD2 chimeric antigen receptor T cells in xenograft models of neuroblastomaNathan Singh, Xiaojun Liu, Jessica Hulitt, et al.
British Journal of Haematology|May 11, 2011
Statins are active in acute lymphoblastic leukaemia (ALL): a therapy that may treat ALL and prevent avascular necrosisCecilia Sheen, Tiffaney Vincent, David Barrett, et al.
Journal of Visualized Experiments : Jove|August 22, 2023
Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell ProcessorRene Machietto, Nicholas Giacobbe, Jessica Perazzelli, et al.
Cytotherapy|May 17, 2017
Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell functionNathan Singh, Ted J Hofmann, Zachary Gershenson, et al.
Cancer Medicine|December 27, 2024
CD4<sup>+</sup> T Cells Mediate Dendritic Cell Licensing to Promote Multi-Antigen Anti-Leukemic Immune ResponseLuis Gil-de-Gómez, Joseph J Mattei, Jessica H Lee, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: stem cell transplantationStephan A Grupp, Christopher C Dvorak, Michael L Nieder, et al.
Transplantation and Cellular Therapy|April 8, 2021
Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric PatientsDanielle E Arnold, Derek MacMath, Alix E Seif, et al.
European Journal of Immunology|March 16, 2017
IFN-γ directly inhibits murine B-cell precursor leukemia-initiating cell proliferation early in lifeMario Fidanza, Alix E Seif, Sumin Jo, et al.
Pageof 24